Student or educator? Sign up with your school email and get 6 months of Pro free.
CoChat

The DOI matches its Crossref record; 210 of the 210 references it cites were found in a registry or an index.

Microbiota in inflammatory bowel disease: mechanisms of disease and therapeutic opportunities

Open access
Iliev, Iliyan D., Ananthakrishnan, Ashwin N., Guo, Chun-Jun · 2025 · Nature Reviews Microbiology

Abstract

Perturbations in the intestinal microbiome are strongly linked to the pathogenesis of inflammatory bowel disease (IBD). Bacteria, fungi and viruses all make up part of a complex multi-kingdom community colonizing the gastrointestinal tract, often referred to as the gut microbiome. They can exert various effects on the host that can contribute to an inflammatory state. Advances in screening, multiomics and experimental approaches have revealed insights into host-microbiota interactions in IBD and have identified numerous mechanisms through which the microbiota and its metabolites can exert a major influence on the gastrointestinal tract. Looking into the future, the microbiome and microbiota-associated processes will be likely to provide unparalleled opportunities for novel diagnostic, therapeutic and diet-inspired solutions for the management of IBD through harnessing rationally designed microbial communities, powerful bacterial and fungal metabolites, individually or in combination, to foster intestinal health. In this Review, we examine the current understanding of the cross-kingdom gut microbiome in IBD, focusing on bacterial and fungal components and metabolites. We examine therapeutic and diagnostic opportunities, the microbial metabolism, immunity, neuroimmunology and microbiome-inspired interventions to link mechanisms of disease and identify novel research and therapeutic opportunities for IBD.

Overview

Integrity signals

Registry

Crossref · 10.1038/s41579-025-01163-0

Cites

210 of 210 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 210 references

Cited by

See all 284

Metadata

Authors
Iliev, I. D., Ananthakrishnan, A. N., & Guo, C.-J.
Affiliations
  • Cornell University (US)
  • Harvard University (US)
Corresponding author
Iliev, Iliyan D.
Venue
Nature Reviews Microbiology
Published
2025-03-10
Volume
23
Issue
8
Pages
509-524
ISSN
  • 1740-1526 (ISSN-L)
  • 1740-1534
OpenAlex
W4408295662
Cited by
249
References
210
Citations by year
2026: 183 · 2025: 66
FWCI
22.04
Type
journal article
Language
en
Open access
Licence
Locations
  • Nature Reviews Microbiology (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
Funders
  • National Cancer Institute (R01CA286920)
  • National Institute of Allergy and Infectious Diseases (R01AI178683, R01AI172027, R01AI163007)
  • National Institute of Diabetes and Digestive and Kidney Diseases (R01DK121977, R01DK132244, R01DK135816, R01DK113136)
  • National Center for Complementary and Integrative Health (R01AT013241)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
  • Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
  • Health Sciences › Medicine › Gastroenterology › Microscopic Colitis
Keywords
inflammatory bowel disease, gut microbiota, host-microbiota interactions, bacterial metabolites, fungal metabolites, microbial metabolites, intestinal immunity, neuroimmunology, enteric nervous system, microbiota-based therapy, microbiome diagnostics, diet and microbiome
MeSH terms
Gastrointestinal Microbiome, Animals, Bacteria, Fungi, Humans, Inflammatory Bowel Diseases, Gastrointestinal Tract, Dysbiosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Microbiota in inflammatory bowel disease: mechanisms of disease and therapeutic opportunities. https://app.cochat.ai/papers/10.1038/s41579-025-01163-0
The paper
Iliev, I. D., Ananthakrishnan, A. N., & Guo, C.-J. (2025). Microbiota in inflammatory bowel disease: mechanisms of disease and therapeutic opportunities. Nature Reviews Microbiology. https://doi.org/10.1038/s41579-025-01163-0

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.